Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Gascon

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Blood|February 1, 1985
Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of antithymocyte globulinP Gascon, N C Zoumbos, G Scala, et al.
Journal Francais D'Ophtalmologie|May 28, 2016
[Eplerenone treatment in chronic central serous chorioretinopathy]M Sampo, V Soler, P Gascon, et al.
Journal Francais D'Ophtalmologie|June 18, 2022
Acute macular neuroretinopathy after COVID-19 vaccineT Michel, N Stolowy, P Gascon, et al.
The New England Journal of Medicine|November 29, 1984
A prospective clinical and immunologic analysis of patients with serum sicknessT J Lawley, L Bielory, P Gascon, et al.
The Journal of Investigative Dermatology|July 1, 1985
A study of human serum sicknessT J Lawley, L Bielory, P Gascon, et al.
American Journal of Human Genetics|November 1, 1989
Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemiaA Grossman, R T Silver, Z Arlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Cloning of human preprotachykinin-I promoter and the role of cyclic adenosine 5'-monophosphate response elements in its expression by IL-1 and stem cell factorJ Qian, G Yehia, C Molina, et al.
Transactions of the Association of American Physicians|January 1, 1984
Human serum sicknessT J Lawley, L Bielory, P Gascon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2017
Pooled analysis of two randomized, double-blind trials comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancerK Blackwell, P Gascon, C M Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2009
Development of a new G-CSF product based on biosimilarity assessmentP Gascon, U Fuhr, F Sörgel, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Blood|February 1, 1985
Lymphokine abnormalities in aplastic anemia: implications for the mechanism of action of antithymocyte globulinP Gascon, N C Zoumbos, G Scala, et al.
Journal Francais D'Ophtalmologie|May 28, 2016
[Eplerenone treatment in chronic central serous chorioretinopathy]M Sampo, V Soler, P Gascon, et al.
Journal Francais D'Ophtalmologie|June 18, 2022
Acute macular neuroretinopathy after COVID-19 vaccineT Michel, N Stolowy, P Gascon, et al.
The New England Journal of Medicine|November 29, 1984
A prospective clinical and immunologic analysis of patients with serum sicknessT J Lawley, L Bielory, P Gascon, et al.
The Journal of Investigative Dermatology|July 1, 1985
A study of human serum sicknessT J Lawley, L Bielory, P Gascon, et al.
American Journal of Human Genetics|November 1, 1989
Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemiaA Grossman, R T Silver, Z Arlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2001
Cloning of human preprotachykinin-I promoter and the role of cyclic adenosine 5'-monophosphate response elements in its expression by IL-1 and stem cell factorJ Qian, G Yehia, C Molina, et al.
Transactions of the Association of American Physicians|January 1, 1984
Human serum sicknessT J Lawley, L Bielory, P Gascon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2017
Pooled analysis of two randomized, double-blind trials comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancerK Blackwell, P Gascon, C M Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2009
Development of a new G-CSF product based on biosimilarity assessmentP Gascon, U Fuhr, F Sörgel, et al.
Pageof 10